Skip to main content
. 2020 Jun 29;2020:5285178. doi: 10.1155/2020/5285178

Table 2.

Multivariable logistic regression analysis for the outcomes.

Sustained ROSC One-month survival Six-month good neurologic outcome
OR (95% CI) p OR (95% CI) p OR (95% CI) p
Heart rate group
Bradycardia 0.79 (0.23–2.75) 0.711 1.92 (0.41–9.10) 0.411 1.69 (0.29–9.82) 0.558
Normal HR 1.00 (Reference) 1.00 (Reference) 1.00 (Reference)
Tachycardia 1.23 (0.54–2.82) 0.624 0.70 (0.27–1.79) 0.449 0.79 (0.29–2.16) 0.642
Extreme tachycardia 11.30 (1.35–94.53) 0.025 0.82 (0.27–2.49) 0.724 0.92 (0.28–3.08) 0.896
Age, per 10 years 0.85 (0.66–1.11) 0.230 0.82 (0.66–1.02) 0.079 0.80 (0.63–1.02) 0.073
Male 0.73 (0.34–1.57) 0.427 2.15 (1.02–4.55) 0.045 3.45 (1.56–21.50) 0.009
Witnessed arrest 2.15 (0.91–5.11) 0.083 1.30 (0.49–3.46) 0.605 0.96 (0.34–2.65) 0.929
Public place 1.84 (0.56–6.02) 0.313 1.11 (0.42–2.96) 0.829 1.83 (0.66–5.07) 0.245
Shockable initial rhythm 1.19 (0.37–3.84) 0.268 3.03 (1.22–7.51) 0.017 3.18 (1.25–8.10) 0.015
Bystander CPR 1.67 (0.67–4.16) 0.268 1.81 (0.76–4.34) 0.182 1.87 (0.71–4.91) 0.205
Total epinephrine dose, per 1 mg 0.89 (0.75–1.05) 0.152 0.69 (0.52–0.92) 0.011 0.77 (0.57–1.04) 0.083
MAP ≥ 80 mmHg at ROSC 0.90 (0.43–1.88) 0.778 2.21 (0.98–4.97) 0.056 1.84 (0.76–4.43) 0.175
No-flow time, per 1 min 1.02 (0.98–1.06) 0.395 0.95 (0.91–1.00) 0.057 0.94 (0.89–0.99) 0.042
Low-flow time, per 1 min 0.99 (0.97–1.02) 0.716 0.95 (0.91–0.98) 0.005 0.94 (0.91–0.98) 0.007

Bradycardia, HR < 60 beats/min; normal, 60 ≤ HR ≤ 100 beats/min; tachycardia, 100 < HR < 150 beats/min; extreme tachycardia, HR ≥ 150 beats/min. ROSC, return of spontaneous circulation; OR, odds ratio; CI, confidence interval; HR, heart rate; CPR, cardiopulmonary resuscitation; MAP, mean arterial pressure. Statistically significant.